Mimedx (MDXG) Gross Margin Growth (5y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Mimedx | 530.69 Mn | 370.92 Mn | 41.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,336.00 |
| Dec 31, 2025 | -35.00 |
| Sep 30, 2025 | -46.00 |
| Jun 30, 2025 | -366.00 |
| Mar 31, 2025 | -253.00 |
| Dec 31, 2024 | -157.00 |
| Sep 30, 2024 | -337.00 |
| Jun 30, 2024 | -258.00 |
| Mar 31, 2024 | -419.00 |
| Dec 31, 2023 | -471.00 |
| Sep 30, 2023 | -964.00 |
| Jun 30, 2023 | -700.00 |
| Mar 31, 2023 | -621.00 |
| Dec 31, 2022 | -862.00 |
| Sep 30, 2022 | -693.00 |
| Jun 30, 2022 | -714.00 |
| Mar 31, 2022 | -520.00 |
| Dec 31, 2021 | -99.00 |
| Sep 30, 2021 | -365.00 |
| Jun 30, 2021 | -582.00 |
| Mar 31, 2021 | -119.00 |
| Dec 31, 2020 | -616.00 |
| Sep 30, 2020 | -584.00 |
| Jun 30, 2020 | -414.00 |
| Mar 31, 2020 | -361.00 |
| Dec 31, 2019 | -754.00 |
| Sep 30, 2019 | -487.00 |
| Jun 30, 2019 | -374.00 |
| Mar 31, 2019 | 407.00 |
| Dec 31, 2018 | 605.00 |
| Sep 30, 2018 | 466.00 |
| Jun 30, 2018 | 656.00 |
| Mar 31, 2018 | 536.00 |
| Dec 31, 2017 | 537.00 |
| Sep 30, 2017 | 684.00 |
| Jun 30, 2017 | 1,229.00 |
| Mar 31, 2017 | 1,421.00 |
| Dec 31, 2016 | 2,179.00 |
| Sep 30, 2016 | 2,878.00 |
| Jun 30, 2016 | 3,090.00 |
| Mar 31, 2016 | 5,316.00 |